Prospective in vitro testing for drug-induced neutropenia in a patient requiring anti-malarial prophylaxis: confirmation of findings on exposure of patient to drug
- 28 June 2008
- journal article
- case report
- Published by Wiley in Clinical and Laboratory Haematology
- Vol. 12 (1) , 31-36
- https://doi.org/10.1111/j.1365-2257.1990.tb01107.x
Abstract
A patient with moderate pancytopenia thought to be due to chloroquine ingestion was shown to have granulocyte progenitors (CFU-G) which were abnormally sensitive in vitro to chloroquine. As he required further anti-malarial prophylaxis, his marrow was prospectively tested in vitro with proguanil and its metabolite cycloguanil. The patient's CFU-G were also abnormally sensitive to these agents and predicted neutropenia was verified when the patient had a trial course of proguanil. We believe this is the first instance of in vivo confirmation of in vitro CFU-G drug sensitivities.Keywords
This publication has 6 references indexed in Scilit:
- Neutropenia associated with dual antimalarial chemoprophylaxis — Use of bone-marrow culture as an aid in further drug managementJournal of Infection, 1987
- The CFU-C assay in patients with neutropenia and, in particular, drug associated neutropeniaClinical and Laboratory Haematology, 1987
- Ticarcillin-Induced Neutropenia Corroborated by in vitro CFU-C ToxicityActa Haematologica, 1983
- Quinine-induced agranulocytosis: toxic effect of quinine bisulphate on bone marrow cultures in vitro.BMJ, 1977
- Amidopyrine agranulocytosis:drug inhibition of granulocyte colonies in the presence of patient's serum.BMJ, 1976
- Amodiaquine-induced Agranulocytosis: Toxic Effect of Amodiaquine in Bone Marrow Cultures In VitroBMJ, 1973